These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36485092)

  • 1. New developments in ALL in AYA.
    Boissel N
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):190-196. PubMed ID: 36485092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
    Grover P; Muffly L
    Curr Oncol Rep; 2022 Aug; 24(8):995-1001. PubMed ID: 35353349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment development for T cell acute lymphoblastic leukemia in children, adolescents, and young adults].
    Sato A
    Rinsho Ketsueki; 2022; 63(9):1325-1334. PubMed ID: 36198559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat acute lymphoblastic leukemia in older adolescents and young adults.
    Curran E; Stock W
    Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
    Testi AM; Canichella M; Vitale A; Piciocchi A; Guarini A; Starza ID; Cavalli M; De Propris MS; Messina M; Elia L; Moleti ML; Martino B; Luppi M; D'Aloisio M; Candoni A; Conter V; Fazi P; Vignetti M; Chiaretti S; Foà R
    Am J Hematol; 2021 Mar; 96(3):292-301. PubMed ID: 33284999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lymphoblastic leukemia in young adults: which up-front treatment?
    Molina JC; Rotz S
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):573-580. PubMed ID: 38066875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults].
    Yamazaki E
    Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute lymphoblastic leukemia in adolescents and young adults].
    Hayakawa F
    Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adolescents and young adults with acute lymphoblastic leukemia. A specific management].
    Boissel N; Ducassou S
    Bull Cancer; 2017; 104(7-8):683-689. PubMed ID: 28576259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategy for treatment of acute lymphoblastic leukemia].
    Kobayashi Y
    Rinsho Ketsueki; 2018; 59(10):2019-2027. PubMed ID: 30305504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
    Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R
    Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
    Mannis GN; Martin TG; Damon LE; Andreadis C; Olin RL; Kong KA; Faham M; Hwang J; Ai WZ; Gaensler KML; Sayre PH; Wolf JL; Logan AC
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1030-1036. PubMed ID: 26899561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
    Orellana-Noia VM; Douvas MG
    Curr Hematol Malig Rep; 2018 Apr; 13(2):100-108. PubMed ID: 29442287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
    Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should we treat the AYA patient with newly diagnosed ALL?
    Boissel N
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):175-183. PubMed ID: 29050690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
    Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
    J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph-negative acute lymphoblastic leukemia.
    Nagafuji K; Miyamoto T; Eto T; Ogawa R; Okumura H; Takase K; Kawano N; Miyazaki Y; Fujisaki T; Wake A; Ohno Y; Kurokawa T; Kamimura T; Takamatsu Y; Yokota S; Akashi K
    Eur J Haematol; 2019 Sep; 103(3):164-171. PubMed ID: 31132205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
    Czyz A; Lewandowski K; Kroll R; Komarnicki M
    Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
    Burke MJ; Gossai N; Wagner JE; Smith AR; Bachanova V; Cao Q; MacMillan ML; Stefanski HS; Weisdorf DJ; Verneris MR
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):138-42. PubMed ID: 22960388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.